Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients

A B Cefalù1, C M Barbagallo, E Sesti

  • 1Istituto di Medicina Interna e Geriatria, Department of Internal Medicine, University of Palermo, Policlinico Paolo Giaccone, Italy.

Insights

Familial defective apolipoprotein B-100, a genetic cause of high cholesterol, was studied in Italy. The Arg3500Gln mutation prevalence was low, associated with a specific gene haplotype.

Area of Science:

  • Genetics
  • Biochemistry
  • Cardiovascular Medicine

Background:

  • Familial hypercholesterolemia is a common genetic disorder characterized by high cholesterol levels.
  • Familial defective apolipoprotein B-100 (apo B-100) is a significant genetic cause of hypercholesterolemia.
  • Specific mutations in the apo B gene, particularly around codon 3500, lead to defective apo B-100.

Purpose of the Study:

  • To investigate the prevalence of familial defective apo B-100, specifically the Arg3500Gln mutation, in Italian populations.
  • To identify and characterize new cases of familial defective apo B-100 in Italy.
  • To analyze the apo B gene haplotype co-segregating with the Arg3500Gln mutation in Italian families.

Main Methods:

  • Screening of probands diagnosed with Familial Hypercholesterolemia from mainland Italy and Sicily.
  • Genetic analysis to identify specific mutations (Arg3500Gln, Arg3531Cys) in the apo B gene.
  • Haplotype analysis of the apo B gene in affected families.

Main Results:

  • Three new Italian families with the Apo B Arg3500Gln mutation were identified (one from Liguria, two from Sicily).
  • The prevalence of the Apo B Arg3500Gln mutation was found to be low (0.28% in mainland Italy, 0.65% in Sicily).
  • The Apo B Arg3531Cys mutation was not detected in any of the screened individuals.
  • The Arg3500Gln mutation consistently co-segregated with a specific apo B haplotype in Italian families, consistent with previous findings in Caucasian populations.

Conclusions:

  • Familial defective apo B-100 due to the Arg3500Gln mutation is present but rare in the studied Italian populations.
  • The identified apo B haplotype provides a genetic marker for this mutation in Italy.
  • Further research may be warranted to understand the geographical distribution and clinical impact of this mutation in diverse populations.

Related Concept Videos

Pedigree Analysis02:21

Pedigree Analysis

A pedigree is a diagram displaying a family’s history of a trait. Analyzing pedigrees can reveal (1) whether a trait is dominant or recessive, (2) the type of chromosome, autosomal or sex, a trait is linked to, (3) genotypes of family members, and (4) probabilities of phenotypes in future generations. For families with a history of autosomal or sex-linked diseases, this information can be crucial to family planning.Pedigrees Display Family HistoriesIn various plant and animal species,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic Lingo02:25

Genetic Lingo

An organism is diploid if it inherits two variants, or alleles, of each gene, one from each parent. These two alleles constitute the genotype for a given gene. The term genotype is also used to refer to an organism’s complete set of genes. A diploid organism with two identical alleles has a homozygous genotype, whereas two different alleles indicate a heterozygous genotype. Observable traits arising from genotypes are called phenotypes, which can also be influenced by environmental factors. An...
Pleiotropy01:47

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...